How pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
Terry Branstad
Advertisement
Articles by Terry Branstad
Advertisement
Latest Updated Articles
Elevating ESG Message: Today’s Modern Investor is KeyAugust 17th 2022
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
2
FDA Approves Wegovy HD Injectable Under Accelerated Approval
3
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5